INTERNATIONAL PATENT: SKYLINE THERAPEUTICS (SHANGHAI) CO., LTD., SKYLINE THERAPEUTICS LIMITED, BIOMARIN PHARMACEUTICAL INC. FILES APPLICATION FOR "TREATMENT OF GENETIC CARDIOMYOPATHIES WITH AAV GENE THERAPY VECTORS"

GENEVA, Oct. 18 -- SKYLINE THERAPEUTICS (SHANGHAI) CO., LTD. (Room 01, 2nd Floor, Building C, 2727 Jinke RoadPudong New Area, Shanghai 201203), SKYLINE THERAPEUTICS LIMITED (PO BOX 309, Ugland House, Grand CaymanKY1-1104), BIOMARIN PHARMACEUTICAL INC. (105 Digital Drive, NovatoCalifornia 94949) filed a patent application (PCT/CN2025/088527) for "TREATMENT OF GENETIC CARDIOMYOPATHIES WITH AAV GENE THERAPY VECTORS" on Apr 11, 2025. With publication no. WO/2025/214477, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOU, Jin...